EP3416627
ORAL DOSAGE FORM COMPRISING RIFAXIMIN IN FORM BETA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
25.4.2018EP published:
27.11.2019EP application number:
18718476.7
EPO information:
European Patent Register
Max expiry date:
24.4.2038
Title:
ORAL DOSAGE FORM COMPRISING RIFAXIMIN IN FORM BETA
Timeline
Today
25.4.2018EP application
27.11.2019EP Publication
Owner
Name:
Sandoz AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
SCHWARZ, Franz XaverAddress:
Kundl, AT
Priority
Number:
17168281Date:
26.4.2017Country:
EP
Classification
Categories:
A61K 9/20, A61K 31/437